Crossmark

Early Impact of Dupilumab in Disease Severity and Quality of Life of Patients Affected by Moderate-to-severe Atopic Dermatitis: A Prospective Study

Crossref DOI link: https://doi.org/10.1016/j.ad.2024.04.027

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Garriga-Martina, G.G.

Suárez-Pérez, J.A.

Martínez-García, E.A.

Herrera-Acosta, E.
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-07-02
More Information

This article is maintained by: Elsevier

Article Title: Early Impact of Dupilumab in Disease Severity and Quality of Life of Patients Affected by Moderate-to-severe Atopic Dermatitis: A Prospective Study

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2024.04.027

Content Type: simple-article

Copyright: © 2024 AEDV. Published by Elsevier España, S.L.U.